|
(ÁÖ) ¸ÞµðÆÁ |
ÀÇ·á±â±â ÀÎÇã°¡ Àü¹®°¡/°æ·Â 2³âÀÌ»ó
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Çмú/±³À°/»ó´ã |
2³â¡è |
ä¿ë½Ã |
02.07 |
|
|
¾ÆÀÌÄÜŬ¸®´ÏÄø®¼Ä¡ |
Global CRO ICON Korea CRA II / Sr. Contract & Grant Anal
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
03.11 |
|
|
À̳ëºê·¹ÀÎ |
Senior Quality Standards Associate Ãʺù
¼¿ï °ºÏ±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
12.07 |
|
|
(ÁÖ)ÇÁ·Î¸ÅÄ¡ÄÚ¸®¾Æ |
±¹³» ÀÇ·á±â±âȸ»ç ¿¬±¸°³¹ß
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
2³â¡è |
ä¿ë½Ã |
04.21 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Feasibility - Site ID Specialist
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
SSU |
2³â¡è |
ä¿ë½Ã |
07.21 |
|
|
(ÁÖ)KDC³×Æ®¿÷½º |
Business Developer(CRO ¿µ¾÷ °æ·ÂÀÚ)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
02.28 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] HR Associate ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Àλç/ÀÎÀç°³¹ß/ä¿ë/±³À° |
2³â¡è |
ä¿ë½Ã |
04.23 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] PV Associate ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
04.23 |
|
|
ºê·¹ÀÎÇãºê |
[ÇìµåÇåÆÃ]±Û·Î¹ú ¸ÞµðÄà Áø´ÜÀåºñ ȸ»ç-ÀÓ»ó °æ·ÂÀÚ Ã¤¿ë
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
09.23 |
|
|
Â÷¸ÞµðÅØ |
Â÷¸ÞµðÅØ ÀÇ·á±â±â(MD) ¿¬±¸°³¹ß ¸ðÁý (´ëÀü)
´ëÀü À¯¼º±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
2³â¡è |
ä¿ë½Ã |
08.25 |
|
|
Æ÷Ƽ½ºÆÄÆ®³Ê½º |
Top ¹Ì±¹°è ºñ Á¦¾à»ç) Medical Sales Rep ASAP ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
¿µ¾÷°ü¸®/¿µ¾÷Áö¿ø |
2³â¡è |
ä¿ë½Ã |
09.07 |
|
|
(ÁÖ)»çÀ̳ؽº |
¹°·ùÆÀ(ICC Inventory) °æ·ÂÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
2³â¡è |
ä¿ë½Ã |
11.14 |
|
|
A&T Consulting |
Clinical Research Associate
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
10.10 |
|
|
¿¥¾ÆÀ̾ËȦµù½º |
´ë±â¾÷-´ëÇ¥ÀÌ»ç ºñ¼
¼¿ï ±¸·Î±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
ºñ¼/¾È³»/Åë¹ø¿ª |
2³â¡è |
ä¿ë½Ã |
02.07 |
|
|
ÈÞÁ©(ÁÖ) |
[ÀÇÇÐÁ¤º¸ÆÀ] MIS °æ·Â
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
2³â¡è |
»ó½Ãä¿ë |
07.11 |
|